Cowen Raises Price Target on AbbVie (ABBV) Due to Enhanced Visability
Tweet Send to a Friend
Cowen maintains an Outperform rating on Abbvie (NYSE: ABBV), and raised the price target to $72.00 (from $70.00) to show ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
